Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis
Florent Artru, Lorenzo Alberio, Darius Moradpour, G. Stalder
Abstract
We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reasonable to evoke ITP in case of profound thrombocytopaenia in a patient with COVID-19.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Purpura (gastropod)DexamethasoneImmune systemCirrhosisAntibodyDisease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyGastroenterologyInternal medicineInfectious disease (medical specialty)VirologyBiologyOutbreakEcologyPlatelet Disorders and TreatmentsBlood properties and coagulationPancreatitis Pathology and Treatment